Sir Murray Frederick Brennan GNZM (born 2 April 1940) is a New Zealand surgeon, oncologist, cancer researcher, and academic. From 1985 to 2006, he was chairman of the surgery department of the Memorial Sloan Kettering Cancer Center in New York City, United States.
Born in the Auckland suburb of Onehunga in 1940, and educated first at Onehunga Primary School [1] [2] Brennan attended the University of Otago, gaining a BSc in 1962, and MB ChB in 1964. [3] A rugby union player, he played 12 matches for Otago between 1964 and 1965. [4] He also served as president of the Otago University Students' Association. [4]
In 1967 he was appointed as an assistant lecturer in physiology and surgery at Otago, [3] and in 1970 he moved to the United States and undertook laboratory and clinical work at Peter Bent Brigham Hospital, Harvard Medical School and the Joslin Research Laboratories. After a period as head of the surgical metabolism section at the National Cancer Institute, he became chief of the gastric and mixed tumor service at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City in 1981. Between 1985 and 2006 he was chairman of the surgery department at MSKCC. [5]
Brennan has authored over 1000 publications and has served on the editorial board the Australian and New Zealand Journal of Surgery since 1985. [4] [6]
He co-founded Dugri in 2020, where he has worked with Jonathan Lewis, Yotam Dagan and others to help hone the development of next-generation technology platforms for scale in the management of operational stress management and PTSD. [7]
Brennan was awarded an honorary Doctor of Science (DSc) degree by the University of Otago in 1997. [8] In the 2015 New Year Honours, he was awarded one of New Zealand's highest honours when he was appointed Knight Grand Companion of the New Zealand Order of Merit for services to medicine. [6] [9]
Harold Eliot Varmus is an American Nobel Prize-winning scientist who was director of the National Institutes of Health from 1993 to 1999 and the 14th Director of the National Cancer Institute from 2010 to 2015, a post to which he was appointed by President Barack Obama. He was a co-recipient of the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in New York City, founded in 1884 as the New York Cancer Hospital. MSKCC is the largest and oldest private cancer center in the world, and is one of 51 National Cancer Institute–designated Comprehensive Cancer Centers. Its main campus is located at 1275 York Avenue, between 67th and 68th streets, in Manhattan.
Proponents of Metabolic typing believe that each person has a unique metabolism, and that the proportion of macromolecules which are optimal for one person may not be for a second, and could even be detrimental to them.
Monica Morrow is a breast cancer surgeon and Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center in Manhattan, NY. Her first day seeing patients in clinic as Chief at MSKCC was Tuesday, February 19, 2008. She formerly served as the chairman of surgical oncology at the Fox Chase Cancer Center. She is the President-elect of the Society for Surgical Oncology.
José Baselga is a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Baselga served as Physician-in-Chief at the Memorial Sloan Kettering Cancer Center until his resignation in September 2018 after it was reported that he had failed to disclose millions of dollars in financial ties with pharmaceutical companies in his research. On January 7, 2019, AstraZeneca announced that they had hired him as head of research and development in oncology.
The Tri-Institutional Training Program in Computational Biology and Medicine or Tri-I CBM is a PhD program that exists as a partnership between the Weill Cornell Medical College (WMC), Rockefeller University, and Memorial Sloan-Kettering Cancer Center (MSKCC). The program is in part designed to encourage collaboration and a sense of connectedness between the two branches of Cornell University and the other institutions in Manhattan. Dr. Christina Leslie is the current director of the program.
William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.
The Band of Parents is a 501c3 nonprofit organization. Formed in July 2007 and incorporated in October 2007, it was founded by approximately 100 parents of young children with neuroblastoma who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Its purpose is to fund the development of new therapies for neuroblastoma that would not otherwise be pursued by research institutions or the pharmaceutical industry. The organization has become the largest single funder of neuroblastoma research at MSKCC.
Jonathan J. Lewis, M.D., Ph.D., is a surgeon, biomedical researcher and entrepreneur. He was trained in surgery in South Africa, Britain, and the United States, and is a fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was awarded an MB.B.Ch. from University of the Witwatersrand School of Medicine, and his Ph.D. in Molecular Biology from Witwatersrand and Yale School of Medicine. He completed his Surgical Residency at Charlotte Maxeke Johannesburg Academic Hospital and at Yale-New Haven Hospital. Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, before working in the biotechnology and healthcare industries, serving in several CEO and Chairman roles. He is currently chairman and co-founder of the Molecular Ninja Group and chairman and co-founder of Dugri Inc.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Joan Massagué, is a biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a Professor of Medicine at the Weill Cornell Medical College. In 1997 he was appointed chair of the Department of Medicine at Sloan-Kettering.
Dr. Peter T. Scardino is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
John H. Healey is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), as well as Professor of Surgery at Weill Cornell Medical College, in New York, NY.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center, a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, and Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College. He is also a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control. In 2016, he was elected as a Member of the National Academy of Medicine. In 2018, he was named a Fellow of the American Society of Clinical Oncology.
Paul Alan Marks was a medical doctor, researcher and administrator. He was a faculty member and president at Memorial Sloan Kettering Cancer Center.
Nikola Panayot Pavletich is the chair of structural biology at Memorial Sloan Kettering Cancer Center.
Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering.
Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.
